Nayeri Arash, Bhatia Nirmanmoh, Holmes Benjamin, Borges Nyal, Young Michael N, Wells Quinn S, McPherson John A
University of California, Los Angeles, Department of Medicine, 757 Westwood Plaza, St. 7501, Los Angeles, CA, 90095-7417, USA.
Vanderbilt University Medical Center, Nashville, USA.
Heart Vessels. 2017 Nov;32(11):1358-1363. doi: 10.1007/s00380-017-1005-4. Epub 2017 Jun 6.
The prognostic significance of chronic medical illness in comatose survivors of cardiac arrest who undergo targeted temperature management (TTM) remains largely unknown. We sought to assess the association between overall burden of pre-existing medical comorbidity and neurological outcomes in survivors of cardiac arrest undergoing TTM. We analyzed a prospectively collected cohort of 314 patients treated with TTM following cardiac arrest at a tertiary care hospital between 2007 and 2014. Overall burden of medical comorbidity was approximated with the use of the Charlson Comorbidity Index (CCI). Poor neurological outcome at hospital discharge, defined as a cerebral performance category (CPC) score >2, was the primary outcome. Secondary outcomes included death prior to hospital discharge and at 1 year following cardiac arrest. Multivariable logistic regression was used to assess the association between CCI scores and outcomes. A poor neurological outcome at hospital discharge was observed in 193 (61%) patients. One hundred and seventy-nine (57%) patients died prior to hospital discharge and a total of 195 (62%) patients had died at 1-year post-arrest. In multivariable logistic regression, elevated CCI scores were not associated with increased odds of poor neurological outcomes (OR 1.04, 95% CI 0.90-1.19, p = 0.608) or death (OR 0.99, 95% CI 0.86-1.13, p = 0.816) at hospital discharge. No association was seen between CCI scores and death at 1-year post-arrest (OR 1.09, 95% CI 0.95-1.26, p = 0.220). Increasing burden of medical comorbidity, as defined by CCI scores, is not associated with neurological outcomes or survival in patients treated with TTM.
在接受目标温度管理(TTM)的心脏骤停昏迷幸存者中,慢性疾病的预后意义在很大程度上仍不明确。我们试图评估心脏骤停幸存者在接受TTM治疗时,既往合并症的总体负担与神经学预后之间的关联。我们分析了2007年至2014年期间在一家三级医疗中心接受TTM治疗的314例心脏骤停患者的前瞻性队列。使用Charlson合并症指数(CCI)估算合并症的总体负担。出院时神经学预后不良定义为脑功能分类(CPC)评分>2,这是主要结局。次要结局包括出院前及心脏骤停后1年的死亡情况。采用多变量逻辑回归分析评估CCI评分与结局之间的关联。193例(61%)患者出院时神经学预后不良。179例(57%)患者在出院前死亡,共有195例(62%)患者在心脏骤停后1年死亡。在多变量逻辑回归分析中,较高的CCI评分与出院时神经学预后不良几率增加(比值比1.04,95%置信区间0.90 - 1.19,p = 0.608)或死亡(比值比0.99,95%置信区间0.86 - 1.13,p = 0.816)无关。CCI评分与心脏骤停后1年死亡之间未见关联(比值比1.09,95%置信区间0.95 - )。根据CCI评分定义,合并症负担增加与接受TTM治疗患者的神经学预后或生存率无关。